Beta · prototype— This site is under construction: rankings, texts and features change every week.

strategic

Portfolio in Canada · United Kingdom · United States: 3 funded startups tracked by Uback, 3 of them in a ranking.

Portfolio on Uback3startups, 3 countries
In a ranking3ranked by AI-estimated valuation
On the Radar0eligible, not ranked
Latest deal trackedJul 2026Greyparrot

Portfolio on Uback

Sorted by Uback rank, then Radar by last round
CompanyUbackSectorRound backedValuation (AI)
Tessera Therapeutics#7 Gene & cell therapiesHealthtech › Biotech › Gene & cell therapiesSeries D · USD 150–200M (reported range) · Dec 2025Hundreds of M$
Cyclic Materials#8 RecyclingEnergy & climate › Resources › RecyclingSeries C · USD 75M · Jan 2026Hundreds of M$
Greyparrot#22 RecyclingEnergy & climate › Resources › RecyclingSeries B · about EUR 23M (USD 27M) · Jul 2026Hundreds of M$

Only startups that meet Uback’s eligibility rules are shown. Amounts are round sizes, not the fund’s share. Rounds as reported by public sources.

By sector

Energy & climate2
Healthtech1

Deals tracked per year

12025
22026

Co-investors

Regeneron · T. Rowe Price · Canada Growth Fund · BMW i Ventures · Energy Impact Partners · Hitachi Ventures · Microsoft · Amazon · JLR · ERI · Sep 2026 · Omar Mir · Bollegraaf

Investors that joined the same rounds, as reported by public sources.

Last updated: Oct 2026Report a missing dealReport an error

Uback is a content publisher. It provides no investment advice, receives no mandate and takes part in no transaction.